Psychopharmacology Management of Early Psychosis During the COVID-19 Pandemic-Presentation and Q&A

Video Transcription

Video Summary

The video content is a presentation from the Third National Conference on Advancing Early Psychosis Care in the United States, focusing on the psychopharmacology management of early psychosis during the COVID-19 pandemic. The video is moderated by Dr. Rob Cotez, a psychiatrist at Emory University School of Medicine. The faculty presenters are Dr. Anne Hackman, the division director of community psychiatry at the University of Maryland School of Medicine, and Dr. Dost Unger, the William P. and Henry B. Test Professor of Psychiatry at Harvard Medical School and chief of the psychotic disorders division at McLean Hospital. The presenters discuss the impact of the pandemic on society and psychiatry, including disruptions in daily life, economic changes, and changes in medical care. They address the potential increase in psychiatric disorders, including depression, anxiety, and suicidal ideation, as well as substance use and PTSD. The speakers emphasize the need for increased psychiatric services and collaboration between psychiatrists and other medical professionals. They discuss the challenges of prescribing during the pandemic, including the impact on medication availability and potential interactions between psychotropic medications and COVID-19. The presenters also highlight the importance of early intervention, psychoeducation, and the use of long-acting injectables in early psychosis care. They address the challenges of treating substance-induced psychosis and emphasize the need for more data on outcomes in the early psychosis population during the COVID-19 era.

Keywords

psychopharmacology management

early psychosis

COVID-19 pandemic

psychiatry

moderator

faculty presenters

impact of pandemic

psychiatric disorders

increased psychiatric services

prescribing during pandemic